– USA, NY – Applied UV, Inc. (Nasdaq: AUVI), a pathogen elimination technology company today announced the appointment of Dr. Jos Luhukay (Ph.D.) to its Board of Directors, effective on May 17th, 2022.
“We welcome Jos to our Board of Directors. During his distinguished career Jos has demonstrated a track record of providing corporate governance, completing complex financial execution and international regulatory compliance with financial institutions that will complement and broaden our existing Board of Directors. Jos’s international business connections throughout Southeast Asia and Europe will prove valuable as we continue our international expansion. Jos’s leadership and business acumen will provide additional stewardship as we grow our globally recognized suite of both fixed and mobile air purification solutions and is another confident step we are undertaking, as we execute on our global strategy.” said CEO, John Andrews.
About Joseph Luhukay
Jos Luhukay is a seasoned international banking Executive with over 40 years of experience leading many of Indonesia’s leading financial institutions and a former Ernst and Young Partner who led the business advisory and risk consulting practice which provided services in corporate governance, risk management, information systems audit and advisory, internal audit and policy and operational process development. Jos Luhukay’s distinguished career brings Applied UV a strong track record in delivering profitable growth for internationally recognized bank and investment banking companies including COO of Bank Niaga, Bahana Pembinaan Usaha Indonesia, a main Indonesian Government-owned investment Bank, COO and Executive Director of the Jakarta Initiative Task Force where he managed a $65B portfolio and restructured over 20% of it in less than 2 years, President Director of Bank Lippo, where he was awarded “CEO of the Year” in 2006 by SWA Magazine (the largest business magazine in Indonesia), Deputy President of Temasek-owned Bank Danamon and his most recent role as President Director of Rabobank International Indonesia, a 30-year-old Dutch-owned Commercial Bank in Indonesia. Jos Luhukay holds an engineering degree in electrical engineering from the University of Indonesia, and a Master’s and Ph.D. in Computer Science from the University of Illinois at Urbana-Champaign.
Jos Luhukay said, “I am truly looking forward to working with the leadership team in bringing forth our advanced air purification technologies throughout the world. Both the health & medical and waste-reduction in food production, transportation, and storage sectors will benefit highly from these technologies. Given the global conditions we are in, Applied UV offers timely and highly required solutions internationally.”
About Applied UV
Applied UV is focused on the development and acquisition of technology that addresses infection control in the healthcare, hospitality, commercial and municipal markets. The Company has two wholly-owned subsidiaries – SteriLumen, Inc. and Munn Works, LLC. SteriLumen’s Airocide air purification devices are research-backed, clinically proven, and developed for NASA with assistance from the University of Wisconsin. Airocide® is listed as an FDA Class II Medical device and utilizes a proprietary photo catalytic bioconversion technology that draws air into a reaction chamber that converts damaging molds, microorganisms, dangerous airborne pathogens, destructive VOCs, allergens, odors, and biological gasses into harmless water vapor and green carbon dioxide without producing ozone or other harmful byproducts. Airocide applications include healthcare, hospitality, grocery chains, wine-making facilities, commercial real estate, schools, dental offices, post-harvest, grocery, cannabis facilities, and homes. SteriLumen’s connected platform for Data-Driven Disinfection applies the power of ultraviolet light to destroy pathogens safely, thoroughly, and automatically, addressing the challenge of healthcare-acquired infections. Targeted for use in facilities that have high customer turnovers such as hospitals, hotels, commercial facilities, and other public spaces, the Company’s Lumicide platform uses UVC LEDs in several patented designs for infection control in and around high-traffic areas, including sinks and restrooms, killing bacteria, viruses, and other pathogens residing on hard surfaces within devices’ proximity. The Company’s patented in-drain disinfection device, Lumicide Drain, is the only product on the market that addresses this critical pathogen-intensive location.
For more information: https://applieduvinc.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.